The next focusIR Investor Webinar takes place tomorrow with guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHikma Pharmaceuticals Share News (HIK)

Share Price Information for Hikma Pharmaceuticals (HIK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,997.00
Bid: 1,996.00
Ask: 1,998.00
Change: 3.00 (0.15%)
Spread: 2.00 (0.10%)
Open: 1,991.00
High: 2,004.00
Low: 1,969.00
Prev. Close: 1,994.00
HIK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UK BROKER RATINGS: Four Brokers Raise Close Brothers Price Target

Wed, 12th Mar 2014 10:05

LONDON (Alliance News) - The following UK shares received analyst recommendations Wednesday morning:
----------
FTSE 100
----------
BERENBERG CUTS TRAVIS PERKINS PRICE TARGET TO 1800 (1880) PENCE - 'HOLD'
----------
JEFFERIES CUTS LAND SECURITIES TO 'HOLD' ('BUY') - PRICE TARGET 1112 PENCE
----------
JEFFERIES CUTS BRITISH LAND TO 'HOLD' ('BUY')
----------
BERNSTEIN CUTS MORRISON PRICE TARGET TO 220 (270) PENCE - 'MARKET-PERFORM'
----------
CITIGROUP RAISES ASHTEAD GROUP PRICE TARGET TO 1075 (850) PENCE - 'BUY'
----------
GOLDMAN CUTS PERSIMMON TO 'BUY' ('CONVICTION BUY LIST')
----------
MORGAN STANLEY RAISES SHELL PRICE TARGET TO 2500 (2330) PENCE - 'EQUAL-WEIGHT'
----------
MORGAN STANLEY RAISES BP PRICE TARGET TO 525 (490) PENCE - 'EQUAL-WEIGHT'
----------
GOLDMAN RAISES SPORTS DIRECT PRICE TARGET TO 1100 (980) PENCE - 'CL BUY'
----------
CHARLES STANLEY CUTS ADMIRAL GROUP TO 'REDUCE' ('HOLD')
----------
FTSE 250
----------
BERENBERG RAISES CLOSE BROTHERS PRICE TARGET TO 1640 (1330) PENCE - 'BUY'
----------
NUMIS RAISES CLOSE BROTHERS PRICE TARGET TO 1325 (1214) PENCE - 'HOLD'
----------
JPMORGAN RAISES CLOSE BROTHERS PRICE TARGET TO 1480 (1357) PENCE - 'OVERWEIGHT'
----------
UBS RAISES CLOSE BROTHERS PRICE TARGET TO 1420 (1340) PENCE - 'NEUTRAL'
----------
UBS CUTS FENNER PRICE TARGET TO 480 (500) PENCE - 'BUY'
----------
JEFFERIES CUTS FENNER PRICE TARGET TO 490 (505) PENCE - 'BUY'
----------
UBS RAISES KAZAKHMYS PRICE TARGET TO 300 (210) PENCE - 'NEUTRAL'
----------
UBS CUTS N BROWN TO 'SELL' ('NEUTRAL') - TARGET 535 (565) PENCE
----------
UBS CUTS PREMIER FARNELL PRICE TARGET TO 235 (240) PENCE - 'NEUTRAL'
----------
GOLDMAN CUTS RIGHTMOVE TO 'BUY' ('CONVICTION BUY LIST')
----------
GOLDMAN CUTS BARRATT DEVELOPMENTS TO 'NEUTRAL' ('BUY')
----------
GOLDMAN RAISES REDROW TO 'BUY' ('NEUTRAL')
----------
DEUTSCHE BANK CUTS GO-AHEAD GROUP TO 'HOLD' ('BUY') - TARGET 2100 (1640) PENCE
----------
DEUTSCHE BANK RAISES ESURE GROUP PRICE TARGET TO 313 (300) PENCE - 'BUY'
----------
CANACCORD CUTS ESURE GROUP PRICE TARGET TO 295 (305) PENCE - 'BUY'
----------
CITIGROUP RAISES ESURE GROUP PRICE TARGET TO 294 (291) PENCE - 'BUY'
----------
NOMURA RAISES INCHCAPE PRICE TARGET TO 600 (580) PENCE - 'NEUTRAL'
----------
DEUTSCHE BANK RAISES INCHCAPE PRICE TARGET TO 685 (655) PENCE - 'BUY'
----------
INVESTEC CUTS HUNTING TO 'HOLD' ('BUY')
----------
JPMORGAN RAISES MERLIN PRICE TARGET TO 430 (415) PENCE - 'OVERWEIGHT'
----------
JEFFERIES RAISES CAPITAL & COUNTIES PRICE TARGET TO 362 (294) PENCE - 'HOLD'
----------
GOLDMAN RAISES CREST NICHOLSON TO 'CONVICTION BUY LIST' ('BUY')
----------
GOLDMAN RAISES BOVIS HOMES PRICE TARGET TO 1187 (1070) PENCE - 'BUY'
----------
GOLDMAN CUTS SAVILLS PRICE TARGET TO 719 (771) PENCE - 'NEUTRAL'
----------
PANMURE CUTS HIKMA PHARMACEUTICALS TO 'HOLD' ('BUY') - TARGET 1400 (1375) PENCE
----------
MAIN MARKET AND AIM
----------
GOLDMAN RAISES LSL PROPERTY SERVICES PRICE TARGET TO 642 (626) PENCE - 'BUY'
----------
CANACCORD CUTS ROCKHOPPER EXPLORATION PRICE TARGET TO 265 (345) PENCE - 'BUY'
----------
CANACCORD CUTS BROOKS MACDONALD TO 'HOLD' ('BUY') - TARGET 1780 (1620) PENCE
----------
NUMIS RAISES TYMAN PRICE TARGET TO 320 (285) PENCE - 'ADD'
----------
CANACCORD RAISES CAPE PLC PRICE TARGET TO 360 (300) PENCE - 'BUY'
----------
NUMIS CUTS MODERN WATER PRICE TARGET TO 62 (77) PENCE - 'BUY'
----------
PANMURE RAISES PHOENIX IT TO 'BUY' ('HOLD') - TARGET 136 (144) PENCE
----------
Copyright 2014 Alliance News Limited. All Rights Reserved.

More News
3 Jan 2023 09:25

Hikma launches version of Xyrem medicine in US for treating narcolepsy

(Alliance News) - Hikma Pharmaceuticals PLC on Tuesday said it launched an authorised generic version of the Xyrem sodium oxybate prescription medicine in the US for treating narcolepsy.

Read more
3 Jan 2023 09:24

LONDON BROKER RATINGS: Citigroup cuts Wizz Air; Redburn likes CRH

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning, Monday and late Friday:

Read more
3 Jan 2023 09:03

LONDON MARKET OPEN: Stocks jump in first session of 2023

(Alliance News) - Stock prices in London made a strong start to the new year on Tuesday, despite weak Chinese data and the UK suffering a fresh wave of rail strikes.

Read more
3 Jan 2023 07:58

LONDON BRIEFING: Stocks called higher; China factory sector shrinks

(Alliance News) - Stocks in London are expected to start a new year on the front foot on Tuesday, after a mixed session in Asia amid weak Chinese economic data.

Read more
3 Jan 2023 07:46

Hikma launches generic narcolepsy solution in US

(Sharecast News) - Hikma Pharmaceuticals has launched an authorised generic version of Jazz Pharmaceuticals' 'Xyrem 1', or sodium oxybate oral solution, it announced on Tuesday.

Read more
8 Dec 2022 09:48

LONDON BROKER RATINGS: JPMorgan cuts Travis Perkins; BofA likes IAG

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning:

Read more
6 Dec 2022 10:48

RBC Capital Markets starts Hikma at 'outperform'

(Sharecast News) - RBC Capital Markets initiated coverage of Hikma Pharmaceuticals on Tuesday at 'outperform' with a 1,750p price target.

Read more
6 Dec 2022 10:26

LONDON BROKER RATINGS: JPMorgan cuts Lloyds but raises Barclays

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning:

Read more
15 Nov 2022 12:10

Credit Suisse initiates coverage of Hikma at 'outperform'

(Sharecast News) - Credit Suisse has initiated coverage of Hikma Pharmaceuticals with an 'outperform' rating.

Read more
15 Nov 2022 09:58

LONDON BROKER RATINGS: Jefferies cuts Aston Martin to 'underperform'

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and Monday:

Read more
14 Nov 2022 09:25

LONDON BROKER RATINGS: Credit Suisse cuts Ferrexpo to 'neutral'

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and Friday:

Read more
8 Nov 2022 09:39

LONDON BROKER RATINGS: Peel cuts Persimmon; Liberum raises Hammerson

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and Monday:

Read more
3 Nov 2022 11:17

Hikma Pharmaceuticals reiterates 2022 guidance as costs widen

(Alliance News) - Hikma Pharmaceuticals PLC on Thursday reiterated annual guidance for all three of its businesses, continuing to expect them to underperform against 2021 due to rising costs.

Read more
3 Nov 2022 11:08

With tighter purse strings, is parity less probable for the pound?

STOXX 600 down 1.1%

*

Read more
3 Nov 2022 09:28

Banks, insurance dodge carnage as real estate stocks sink

Welcome to the home for real-time coverage of markets brought to you by Reuters reporters. You can share your thoughts with us at .

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.